neoplasm
• mutants develop small tumor foci/buds in the skin; these epithelial invaginations arise from both the hair follicle and the interfollicular epithelium
• tumor buds appear at the first postnatal anagen stage
|
• low incidence in around 10% of mice
|
• low incidence in around 10% of mice
(J:114992)
• 15-20% of mice develop medulloblastomas
(J:144811)
• tumors consist of small round cells with little cytoplasm and clearly demarcated borders
(J:144811)
• 100% of immunocompromised hosts receiving >200,000 tumor cells will develop medulloblastomas with a mean latency of 49 days
(J:144811)
• tumor cells expressing CD15+ have the characteristics of cancer stem cells including high rates of proliferation and ability to propagate the disease into immunocompromised hosts
(J:144811)
|
integument
• small foci of hair loss are observed, each one in association with epithelial invaginations
|
• mutants develop small tumor foci/buds in the skin; these epithelial invaginations arise from both the hair follicle and the interfollicular epithelium
• tumor buds appear at the first postnatal anagen stage
|
nervous system
• low incidence in around 10% of mice
(J:114992)
• 15-20% of mice develop medulloblastomas
(J:144811)
• tumors consist of small round cells with little cytoplasm and clearly demarcated borders
(J:144811)
• 100% of immunocompromised hosts receiving >200,000 tumor cells will develop medulloblastomas with a mean latency of 49 days
(J:144811)
• tumor cells expressing CD15+ have the characteristics of cancer stem cells including high rates of proliferation and ability to propagate the disease into immunocompromised hosts
(J:144811)
|
muscle
• low incidence in around 10% of mice
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
medulloblastoma | DOID:0050902 |
OMIM:155255 |
J:144811 |